Related Experiment Video
Updated: May 31, 2026
08:57
Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models
Published on: May 17, 2024
Primitive chest wall neuroectodermal tumor in a pediatric patient.
Zhengcheng Liu1, Wei Zou, Guodong Ma
1Department of Thoracic Surgery, Nanging Chest Hospital, Nanging, China.
Interactive Cardiovascular and Thoracic Surgery
|July 13, 2011
Summary
A young patient with a primitive neuroectodermal tumor of the chest wall experienced tumor progression after chemotherapy. Surgical resection and further chemotherapy led to a successful outcome with no recurrence one year later.
Area of Science:
- Pediatric Oncology
- Thoracic Surgery
- Cancer Biology
Background:
- Primitive neuroectodermal tumors (PNETs) are rare and aggressive cancers.
- Chest wall PNETs present unique surgical and oncological challenges.
- Early diagnosis and multimodal treatment are crucial for favorable outcomes.
Observation:
- A 13-year-old male presented with a primitive neuroectodermal tumor of the chest wall.
- Imaging revealed tumor progression with invasion into the left upper lung lobe after initial chemotherapy.
- The patient underwent extensive surgical resection and subsequent chemotherapy.
Findings:
- Histopathological and immunohistochemical analyses confirmed the diagnosis of primitive neuroectodermal tumor.
- The surgical procedure included chest wall resection (ribs 4-6), left upper lobectomy, and lymph node dissection.
- Post-operative chemotherapy consisted of four cycles of ifosfamide and etoposide.
Implications:
- This case highlights the successful management of a complex chest wall primitive neuroectodermal tumor in a pediatric patient.
- Aggressive surgical resection combined with neoadjuvant and adjuvant chemotherapy can achieve durable remission.
- Further research into optimal treatment strategies for rare thoracic PNETs is warranted.
